In clinical trials, OZURDEX^® intravitreal implants improved the vision of many patients. It's important to remember that each case of retinal vein occlusion or noninfectious posterior segment uveitis is unique. Your own results may vary.


The OZURDEX^® implant is so tiny that it can be injected into the eye (vitreous) with a procedure in your doctor’s office. Each implant is already inside a special applicator device that is needed to perform the insertion. The implant will be injected into the vitreous humor inside your eye. This is known as an intravitreal injection.

You will be awake during the procedure. Your doctor will follow steps that include ensuring the surface of the eye is clean and numbing the surface of the eye to help keep you comfortable. OZURDEX^® is injected using a special applicator device that’s about the size of a pen.

The applicator is designed to help your doctor deliver OZURDEX^® to the vitreous where the medication is needed. The injection will be complete within seconds, and the procedure is generally well tolerated by patients.

Injections into the vitreous in the eye are associated with serious eye infection (endophthalmitis, pronounced en-dof-thal-my-tis), eye inflammation, increased eye pressure, and retinal detachments. In the days following injection with OZURDEX^®, patients are at risk for serious eye infection or elevated eye pressure. If your eye becomes red, sensitive to light, painful, or develops a change in vision, you should seek immediate care from your eye doctor.

Also, you may experience temporary visual blurring after receiving an injection and should not drive or use machines until this has resolved. These are not the only risks associated with intravitreal injections. If you experience other side effects, you should immediately contact your eye doctor. Your Retina Specialist will discuss the possible risks with you before performing the injection.

Click here to get answers to frequently asked questions about OZURDEX^®.